Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1
3(75.0%)
Phase 4
1(25.0%)
4Total
Phase 1(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03107078Phase 4Unknown

Using A Novel Classification System in Intravenous GCs Therapy of TAO: A Multi-central, Randomized, Open, Superior Trial

Role: lead

NCT02831075Phase 1Unknown

A Clinical Study Using Adipose-derived Stem Cells for Diabetic Foot

Role: lead

NCT02796079Phase 1Unknown

A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications

Role: lead

NCT02834858Phase 1Unknown

Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications

Role: lead

All 4 trials loaded